ERIC BENEVICH - 10 Dec 2024 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Role
Director
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Issuer symbol
ATYR
Transactions as of
10 Dec 2024
Transactions value $
$0
Form type
4
Filing time
12 Dec 2024, 16:15:23 UTC
Previous filing
17 Apr 2024
Next filing
04 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATYR Stock Option (right to buy) Award $0 +100K $0.00 100K 10 Dec 2024 Common Stock 100K $3.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning January 10, 2025, such that this option will be fully exercisable on December 10, 2027, subject to the recipient's continued service on the Issuer's Board of Directors.